{"id":428743,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2014-05-12] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T00:30:30.787000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-9.html","snippet":"Notice: Prescription Drug List (PDL): Multiple additions (PDF Version - 96 K) May 12, 2014 Our file number: 14-105927-39 The purpose of this Notice of Amendment is to notify the addition of Tesamorelin and Tofacitinib to both the Human and Veterinary Prescription Drug List (PDL).…","rawSnapshotUrl":"/api/snapshots/raw/428743","browseUrl":"https://replay.healtharchive.ca/job-6/20260102003030/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-9.html#ha_snapshot=428743","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}